Lenvima and Tongue disorder - a phase IV clinical study of FDA data

Summary:

Tongue disorder is reported as a side effect among people who take Lenvima (lenvatinib mesylate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Vitamin D3, and have Endometrial cancer.

The phase IV clinical study analyzes which people have Tongue disorder when taking Lenvima. It is created by eHealthMe based on reports of 21,107 people who have side effects when taking Lenvima from the FDA, and is updated regularly.

What is Lenvima?

Lenvima has active ingredients of lenvatinib mesylate. eHealthMe is studying from 21,113 Lenvima users. Check the latest studies of Lenvima.

What is Tongue disorder?

Tongue disorder (disease of tongue) is found to be associated with 763 drugs and 964 conditions by eHealthMe. Check the latest studies of Tongue disorder.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

21,107 people reported to have side effects when taking Lenvima.
Among them, 14 people (0.07%) have Tongue disorder.

Among these 14 people:

How long have people been on Lenvima when they have Tongue disorder? *

What is the gender of people who have Tongue disorder when taking Lenvima? *

female: 57.14 %
male: 42.86 %

What is the age of people who have Tongue disorder when taking Lenvima? *

What are other drugs people take besides Lenvima? *

What are other side effects people have besides Tongue disorder? *

High Blood Pressure: 9 people, 64.29%
Nausea (feeling of having an urge to vomit): 6 people, 42.86%
Weakness: 6 people, 42.86%
Nausea And Vomiting: 5 people, 35.71%
Dry Mouth: 5 people, 35.71%
Dizziness: 4 people, 28.57%
Pain: 4 people, 28.57%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 4 people, 28.57%
Stomatitis (inflammation of mucous membrane of mouth): 3 people, 21.43%
Fatigue (feeling of tiredness): 3 people, 21.43%

What are the existing conditions these people have? *

Thyroid Cancer: 4 people, 28.57%
Endometrial Cancer: 4 people, 28.57%
Thyroid Diseases: 2 people, 14.29%
Renal Cell Carcinoma (a kidney cancer): 2 people, 14.29%
Hepatocellular Carcinoma (liver cancer): 2 people, 14.29%
Endometrial Cancer Metastatic: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Lenvima and have Tongue disorder?

- Check whether Tongue disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lenvima:

Lenvima (21,113 reports)

Tongue disorder treatments and more:

Tongue disorder (8,897 reports)

Browse all side effects of Lenvima:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tongue disorder:

Tongue disorder (763 drugs)

Browse all the conditions that are associated with Tongue disorder:

Tongue disorder (964 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on lenvatinib mesylate (the active ingredients of Lenvima) and Lenvima (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.